Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.

ClinicalTrials.gov enrollment closed early-phase tilt small index

Cutaneous Malignant Melanoma: early-phase trial registry

A small indexed set (1 trial) with no open enrollment listed right now.

Corpus placement: #11,370 of 28,707 conditions by registered trial count.

1 US clinical trials · none currently recruiting · #11,370 of 28,707 conditions by registered trial count

Cutaneous Malignant Melanoma: 1 US clinical trial tracked, none currently recruiting.

Cutaneous Malignant Melanoma is the subject of 1 registered US clinical trials on ClinicalTrials.gov, none currently recruiting. 0 are in Phase 3-4 (later-stage) and 1 in Phase 1-2 (earlier-stage). The most active sponsor is Case Comprehensive Cancer Center, running 1 of these trials.

Enrollment posture brief

Registry condition cutaneous-malignant-melanoma

OPEN 0 | RECR 0% | LATE 0 | EARLY 1 | RANK #11370 | SPON 1

Nearest open-share peer: Accelerated Phase Chronic Myelogenous Leukemia (0% recruiting · 12 trials)

Ablation80%ACL Reconstruction80%Abuse, Drug60%Acceptability60%Cutaneous Malignant Mela (th…0%
Open-enrollment share among volume-matched conditions near Cutaneous Malignant Melanoma

Cutaneous Malignant Melanoma has no open enrollment in this registry pull (1 archived studies). Peers show how other volume-matched labels compare on open share. How peer matching works →

Key findings

What ClinicalTrials.gov does not surface for Cutaneous Malignant Melanoma on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.

  1. Cutaneous Malignant Melanoma is recruiting below its size-band peers.

    0 of 1 indexed trials (0%) are open to enrollment, against a 46.5% average across 27,806 conditions with fewer than 20 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.

Phase 11

Phase Distribution

PhaseTrial count
Phase 1 1

Top Sponsors

Named interventions

Most-linked intervention names on Cutaneous Malignant Melanoma records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.

Standard-of-Care Immunotherapy Drug
1 trials
Low Dose Rate Brachytherapy (LDR) Radiation
1 trials

US sites by state

Facility locations filed on Cutaneous Malignant Melanoma trials. A trial with sites in several states counts in each.

Ohio 1 trials

Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.

What to do with this Cutaneous Malignant Melanoma page

1 registered trials, 0 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.

  • No Cutaneous Malignant Melanoma trials are currently recruiting in this registry; that can change as new trials post, or check the broader research index. Browse research indexes
  • Case Comprehensive Cancer Center sponsors the most Cutaneous Malignant Melanoma trials on record, review their full trial history before evaluating a specific study. See Case Comprehensive Cancer Center's trials
  • Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Cutaneous Malignant Melanoma condition card totals 1 registered trials; most-linked intervention Standard-of-Care Immunotherapy; top US site state Ohio. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.